Beijing FTZ publishes a negative list for cross-border data transfer in the medical, retail and AI sectors. Network virtualization needs to provide data encryption protection and satisfy security requirements. Online advertisements should be identifiable as such and not mislead consumers.
China allows fully foreign-owned hospitals and foreign investment in gene technologies; China is assessing the compatibility of the international AI agreement with its own strategic plans; and China's Ministry of Finance strengthens its regulation of foreign accounting organizations, particularly for those that do not have offices in China
Chinese court rules against international hotel brand for misuse of cross-border personal data; EU and China establish mechanism to address difficulties in data transfers; and High-frequency futures traders question their survival in an increasingly hostile Chinese futures market
SPC sets forth criteria for serious money laundering cases and punitive damages for food safety violations. NFRA specifies the conditions for engaging in online property insurance business.
U.S. lawmakers call on the government to scrutinize drugmakers' clinical trials in China; China removes restrictions for foreign investments in the manufacturing and services industries; and Cross-Boundary Wealth Connect gains 10 new additional securities firms for increased offshore investment opportunities.
Nasdaq questioned the identities and backgrounds of Chinese IPO investors; China rolls out new phase of Golden Tax System; and U.S. Congress attempts to prevent Chinese companies from using de minimis loophole to avoid tariffs
SAMR prohibits monopoly agreements that fix or modify pharmaceutical prices. Export pharmaceuticals commissioned for production from a foreign pharmaceutical manufacturer may not be sold and used in the PRC. Guidelines are provided for the methods of monitoring data interface security risks.
U.S. plans to restrict Chinese software in electric and internet-connected cars; China increases control over offshore capital flows; and Chinese firms plan to expand into the U.S. Midwest but have regulatory concerns.
Revised Chinese Company Law requires mandatory worker representation in boardrooms; Shanghai's biomedical measures catch the most attention; and Merchants of Pinduoduo's international arm, Temu, struggle to sue the company due to its complex structure.
WeRide IPO shows another green light for overseas listing of Chinese companies; China imposes new regulations for local authorities to better implement its state secrets law overhaul; and two Chinese state departments release new rules for QFII to stimulate foreign securities investment.
